EYEFIX
ActiveSummary
EYEFIX has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €10.5m and a net result of €7.3m. Equity is growing by ~16% per year across the filed fiscal years. Its solvency ranks better than 59% of 2372 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+28
Solvency95▲+25
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €900,000 at 30 days acceptable
Liquidity ample (current ratio 2.03 against 1.99 in 2024; short-term debt: 6.7% and cash: 10.5% of total assets), and 29.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
70.4%
Return on assets
49%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
371 d late
2023
31 d late
2022
88 d late
2021
26 d late
2020
61 d late
2019
42 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 93 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 1 September (4 of the last 5 filed years within 56 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
In the rankings
#1 company by total assets in Wemmel, Health and social work sector#1 company by equity in Wemmel, Health and social work sector
Equity
€10.5m▲ 210%
2024 · €3.4m
Total assets
€14.9m▲ 99.4%
2024 · €7.5m
Net result
€7.3m▲ 3,393%
2024 · €209,469
Working capital
€1.0m▲ 15.6%
2024 · €881,944
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€33,004▼ 92.9%€199,968▲ 506%€818,792▲ 309%€375,243▼ 54.2%€520,462▲ 38.7%
Net result€6,576below the sector's middle half▼ 98.3%€909,604above the sector's middle half▲ 13,732%€537,975above the sector's middle half▼ 40.9%€209,469within the sector's middle half▼ 61.1%€7.3mabove the sector's middle half▲ 3,393%
Equity€2.4mabove the sector's middle half▲ 0.3%€3.3mabove the sector's middle half▲ 37.8%€3.9mabove the sector's middle half▲ 16.2%€3.4mabove the sector's middle half▼ 12.0%€10.5mabove the sector's middle half▲ 210%
Total assets€3.8mabove the sector's middle half▼ 18.7%€4.7mabove the sector's middle half▲ 24.6%€7.6mabove the sector's middle half▲ 62.0%€7.5mabove the sector's middle half▼ 1.5%€14.9mabove the sector's middle half▲ 99.4%
Debt€1.4m▼ 39.1%€1.4m▲ 1.1%€3.7m▲ 172%€4.1m▲ 9.3%€4.4m▲ 7.7%
Working capital€967,642above the sector's middle half▼ 19.5%€1.9mabove the sector's middle half▲ 96.5%€1.2mabove the sector's middle half▼ 37.5%€881,944within the sector's middle half▼ 25.8%€1.0mabove the sector's middle half▲ 15.6%
Solvency63.9%within the sector's middle half▲ 12.1pp70.7%within the sector's middle half▲ 6.8pp50.7%within the sector's middle half▼ 20.0pp45.3%within the sector's middle half▼ 5.4pp70.4%within the sector's middle half▲ 25.2pp
Current ratio7.95above the sector's middle half▲ 6.1314.79above the sector's middle half▲ 6.844.46within the sector's middle half▼ 10.331.99within the sector's middle half▼ 2.472.03within the sector's middle half▲ 0.04
Return on assets (ROA)0.2%below the sector's middle half▼ 8.0pp19.4%within the sector's middle half▲ 19.2pp7.1%below the sector's middle half▼ 12.3pp2.8%below the sector's middle half▼ 4.3pp49.0%above the sector's middle half▲ 46.2pp
Staff (FTE)1▲ 400%0.4▼ 60.0%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Why a figure moved sharply
- 2024 Net result -61% on 2023. The accounts now follow the abbreviated schema, last year the micro schema.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 39% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €14.9m
Fixed assets
€12.9m ▲ 126%
Current assets
€2.0m ▲ 13.4%
Equity and liabilities €14.9m
Equity
€10.5m ▲ 210%
Debt
€4.4m ▲ 7.7%
Debt's share of the balance-sheet total falls from 54.7% to 29.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€870,221▲
2024 · €755,607
Cash flow
€7.7m▲
2024 · €589,833
Debt to equity
0.42▼
2024 · 1.21
ROE
69.5%▲
2024 · 6.2%
Interest coverage
7.76▲
2024 · 5.95
Debt ≤ 1 year
€994,302▲
2024 · €893,011
Debt > 1 year
€3.4m▲
2024 · €3.2m
Income taxes
€135,585▲
2024 · €101,730
Staff costs
€12,969
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €33,333 | - |
| Remuneration, social security and pensions62 | €50,385 | €12,563 | -€3,493 | - | €12,969 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €120,813 | €180,256 | €82,425 | €380,364 | €349,758 | ▼ 8.0% |
| Other operating charges640/8 | €4,618 | €2,899 | €8,720 | €1,663 | €2,352 | ▲ 41.4% |
| Gross operating margin9900 | €208,820 | €395,686 | €906,444 | €757,270 | €885,542 | ▲ 16.9% |
| Operating profit (loss)9901 | €33,004 | €199,968 | €818,792 | €375,243 | €520,462 | ▲ 38.7% |
| Financial income75/76B | €0 | €850,563 | €2,340 | €62,917 | €7.0m | ▲ 11,096% |
| Recurring financial income75 | €0 | €850,563 | €2,340 | €62,917 | €7.0m | ▲ 11,096% |
| Financial charges65/66B | €24,428 | €28,387 | €68,442 | €126,961 | €112,071 | ▼ 11.7% |
| Recurring financial charges65 | €24,428 | €28,387 | €68,442 | €126,961 | €112,071 | ▼ 11.7% |
| Profit (loss) for the period before taxes9903 | €8,576 | €1.0m | €752,690 | €311,199 | €7.5m | ▲ 2,295% |
| Income taxes67/77 | €2,000 | €112,540 | €214,715 | €101,730 | €135,585 | ▲ 33.3% |
| Profit (loss) for the period9904 | €6,576 | €909,604 | €537,975 | €209,469 | €7.3m | ▲ 3,393% |
| Profit (loss) for the period to be appropriated9905 | €6,576 | €909,604 | €537,975 | €209,469 | €7.3m | ▲ 3,393% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €3.8m | €4.7m | €7.6m | €7.5m | €14.9m | ▲ 99.4% |
| Fixed assets21/28 | €2.7m | €2.7m | €6.1m | €5.7m | €12.9m | ▲ 126% |
| Intangible fixed assets21 | €0 | - | - | - | - | - |
| Tangible fixed assets22/27 | €2.6m | €2.6m | €6.0m | €5.7m | €5.2m | ▼ 8.9% |
| Land and buildings22 | €2.5m | €2.3m | €5.7m | €5.5m | €5.0m | ▼ 8.0% |
| Plant, machinery and equipment23 | €151,858 | €135,045 | €135,045 | €119,299 | €87,565 | ▼ 26.6% |
| Furniture and vehicles24 | €13,029 | €166,008 | €166,535 | €93,067 | €58,101 | ▼ 37.6% |
| Leasing and similar rights25 | €0 | - | - | - | - | - |
| Financial fixed assets28 | €10,650 | €10,650 | €50,326 | €50,326 | €7.8m | ▲ 15,322% |
| Current assets29/58 | €1.1m | €2.0m | €1.5m | €1.8m | €2.0m | ▲ 13.4% |
| Amounts receivable after more than one year29 | €450,000 | €450,000 | €450,000 | €450,000 | - | - |
| Other amounts receivable291 | €450,000 | €450,000 | €450,000 | €450,000 | - | - |
| Amounts receivable within one year40/41 | €83,661 | €339,718 | €281,571 | €114,897 | €441,968 | ▲ 285% |
| Trade receivables40 | €15,661 | €271,700 | €276,631 | - | - | - |
| Other amounts receivable41 | €68,000 | €68,018 | €4,940 | €114,897 | €441,968 | ▲ 285% |
| Current investments50/53 | €480,789 | €5,141 | €5,141 | €11,674 | €6,534 | ▼ 44.0% |
| Cash at bank and in hand54/58 | €90,136 | €1.2m | €795,548 | €1.2m | €1.6m | ▲ 30.6% |
| Deferred charges and accrued income490/1 | €2,256 | - | - | - | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €3.8m | €4.7m | €7.6m | €7.5m | €14.9m | ▲ 99.4% |
| Equity10/15 | €2.4m | €3.3m | €3.9m | €3.4m | €10.5m | ▲ 210% |
| Contributions10/11 | €31,000 | €31,000 | €31,000 | €31,000 | €31,000 | = |
| Reserves13 | €2.1m | €3.3m | €3.8m | €3.4m | €10.5m | ▲ 213% |
| Non-distributable reserves130/1 | €23,790 | €23,790 | €23,790 | €23,790 | €23,790 | = |
| Reserves not available under the articles1311 | €23,790 | €23,790 | €23,790 | €23,790 | €23,790 | = |
| Distributable reserves133 | €2.1m | €3.3m | €3.8m | €3.3m | €10.5m | ▲ 214% |
| Profit (loss) carried forward14 | €266,230 | €835 | €3,810 | €4,279 | €1,639 | ▼ 61.7% |
| Amounts payable17/49 | €1.4m | €1.4m | €3.7m | €4.1m | €4.4m | ▲ 7.7% |
| Amounts payable after more than one year17 | €1.2m | €1.2m | €3.4m | €3.2m | €3.4m | ▲ 6.7% |
| Financial debts170/4 | €1.2m | €1.2m | €3.4m | €3.2m | €3.4m | ▲ 6.7% |
| Amounts payable within one year42/48 | €139,200 | €137,847 | €343,549 | €893,011 | €994,302 | ▲ 11.3% |
| Current portion of amounts payable after more than one year42 | €78,971 | €98,221 | €189,113 | €269,048 | €357,603 | ▲ 32.9% |
| Trade debts44 | €26,253 | €3,561 | €3,817 | €4,000 | €16,743 | ▲ 319% |
| Suppliers440/4 | €26,253 | €3,561 | €3,817 | €4,000 | €16,743 | ▲ 319% |
| Advances received on contracts in progress46 | €1,734 | €1,734 | €1,734 | - | - | - |
| Taxes, remuneration and social security45 | €20,154 | €15,201 | €121,254 | €9,781 | €7,975 | ▼ 18.5% |
| Taxes450/3 | €14,046 | €9,142 | €118,639 | €7,165 | €6,108 | ▼ 14.7% |
| Remuneration and social security454/9 | €6,108 | €6,059 | €2,616 | €2,616 | €1,866 | ▼ 28.6% |
| Other amounts payable47/48 | €12,088 | €19,131 | €27,631 | €610,182 | €611,982 | ▲ 0.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €6,576 | €909,604 | €537,975 | €209,469 | €7.3m | ▲ 3,393% |
| + Depreciation and write-downs630 | €120,813 | €180,256 | €82,425 | €380,364 | €349,758 | ▼ 8.0% |
| Operating cash flow (approximation) | €127,389 | €1.1m | €620,401 | €589,833 | €7.7m | ▲ 1,200% |
| Investment in fixed assets (approximation) | - | -€173,006 | -€3.5m | -€26,317 | -€7.6m | ▼ 28,621% |
| Change in cash | - | €1.2m | -€448,590 | €402,835 | €366,685 | ▼ 9.0% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
06-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 371 days late
2025
31-12
Financial
Highest result since 2018net €7.3m ▲3,393%
Net result €7.3m, the highest in the series.
31-12
Financial
Equity above €10mEq €10.5m ▲210%
8 profitable years in a row build equity to €10.5m.
2024
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
2023
27-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 88 days late
2022
26-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 26 days late
2021
31-12
Financial
Weakest financial yearnet €6,576 ▼98.3%
Net result drops to €6,576, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity quadruplescurrent ratio 7.95
Current ratio from 1.82 to 7.95; short-term debt falls from €1.5m to €139,200.
30-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 61 days late
2020
11-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 42 days late
2019
31-12
Financial
Equity above €2mEq €2.1m ▲12.9%
2 profitable years in a row build equity to €2.1m.
Show earlier events
26-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 26 days late
2018
28-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 28 days late
2017
25-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 56 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wemmel · 2 establishment units since 2010
Ground area
3,033 m²
Building footprint
651 m²
Volume, LiDAR
1,692 m³
2 parcels, Flanders · tallest building 9.8 m, ±2 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
2 establishment units
EYEFIX BVBA
since 20102.184.583.817
Ninoofsesteenweg 240, 1700 Dilbeek
since 20162.263.798.668
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 22005A0496/00C000 | Flanders | 2,058 m² | 1 · 331 m² | 8.5 m · 2 fl. |
| 23352F0150/00G000 | Flanders | 975 m² | 1 · 320 m² | 9.8 m |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 1
-
50%
According to the 2025 annual accounts of EYEFIX and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 1,485 EUR awarded · 1,485 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 1,485 EUR | 1,485 EUR |
Similar companies · same sector, comparable size
DR. PIETER RAUS-OFTALMOLOGIE
BE 0477.082.820
Mol · Eq €9.7m
FANOURAKIS ET AYOUBI
BE 0465.514.777
Nivelles · Eq €9.6m
CABINET MEDICAL DE STOMATOLOGIE DOCTEUR PECHEUR
BE 0859.973.393
Amay · Eq €8.7m
SOBRAD
BE 0470.757.034
Tournai · Eq €8.5m
DOKTER F. GOES JR.
BE 0465.122.324
Schilde · Eq €13.1m
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 1,028 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded28-12-2009
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0821789047
Registered
27-03-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.